[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$SNDX analyst consensus revenue estimates v. $VIE $PRVB $CCXI product sales forecasts by year post M&A Analysts forecast SNDX to generate slightly less sales than CCXI forecast when CCXI was acq for a $3.7B EV.& more than VIE & PRVB acq. for $XXXX & $2.9B resp $INCY $IBB"
X Link @NightOwlBiotech 2025-10-06T17:32Z 1382 followers, XXX engagements
"@StreetCred2017 @ANKITSH85153215 I totally forgot that $CCXI went down this road back when I was a shareholder. Interesting that they went down this road but it was not with CCX168"
X Link @Quick2smile 2025-10-06T11:45Z XXX followers, XX engagements
"$AMGN Breaking: Avacopan seen blocking pancreatic cancer tumors over XX% when combined with gemcitabine/nab-paclitaxel (standard PDAC chemo) XX% Avacopan motherly only - looks like way bigger market for C5aR inhibitor market than just AAV supporting $4b buyout $CCXI $IFRX still at a whopping $100m In vivo CCX168 monotherapy reduced tumor volume by XX% (p0.01); combining it with gemcitabine/nab-paclitaxel (standard PDAC chemo) and immune checkpoint inhibitors (pembrolizumab/ipilimumab) achieved the strongest effectsup to XX% tumor reduction increased CD8+ T-cell infiltration (p0.01) and"
X Link @StreetCred2017 2025-10-05T23:47Z XXX followers, XXX engagements